Journal Article Summary
The article investigates the potential of certain antihistamines to treat acute myeloid leukaemia (AML), a type of cancer that has limited treatment options and poor patient outcomes. Researchers aimed to identify existing FDA-approved drugs that could effectively target leukaemic cells, as there is a pressing need for more effective therapies in this area. By focusing on the dual targeting of lysosomes and mitochondria, the study explores a novel approach that could enhance treatment efficacy while minimizing harm to healthy cells.
To conduct the study, the researchers performed an in silico screening to identify antihistamines that could reverse early leukaemic transformation signatures. They validated their findings using various AML cell lines and primary patient samples, assessing the drugs' cytotoxic effects. The results showed that a specific group of antihistamines, referred to as ANHAs, selectively killed leukaemic cells while sparing healthy cells. These drugs worked by disrupting both lysosomes and mitochondria, leading to cell death through mechanisms such as autophagy and apoptosis.
Despite promising findings, the study has limitations, including the need for further clinical trials to confirm the safety and efficacy of ANHAs in humans. Patients and caregivers should discuss these findings with healthcare professionals, especially regarding potential treatment options and the implications of using antihistamines for AML. It is essential to consider the balance between the benefits of new therapies and the risks associated with their use, particularly in the context of existing health conditions and treatments.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Cornet-Masana Josep M., Banús-Mulet Antònia, Carbó José M., Torrente Miguel Ángel, Guijarro Francesca, Cuesta-Casanovas Laia, Esteve Jordi, Risueño Ruth M.. Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells. EBioMedicine 2019. DOI: 10.1016/j.ebiom.2019.08.021. PMID: 31473184. PMCID: PMC6796581.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
